A new class of DNA alkylating indolino-benzodiazepine agents (BIAs) linked with a DNA binding moiety for use with antibody-drug conjugates (ADCs)

被引：0

|

作者：

Miller, Michael L. ^{[1
]}

Reid, Emily E. ^{[1
]}

Archer, Katie E. ^{[1
]}

Shizuka, Manami ^{[1
]}

McShea, Molly A. ^{[1
]}

Maloney, Erin K. ^{[1
]}

Ab, Olga ^{[1
]}

Lanieri, Leanne ^{[1
]}

Wilhelm, Alan J. ^{[1
]}

Ponte, Jose F. ^{[1
]}

Yoder, Nicholas C. ^{[1
]}

Chari, Ravi V. ^{[1
]}

机构：

[1] ImmunoGen Inc, Waltham, MA USA

来源：

CANCER RESEARCH | 2018年 / 78卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2018-747

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

747

引用

收藏

页数：2

相关论文

共 35 条

[31] A new class of DNA sequence-selective G-A cross-linking antibody-drug conjugate (ADC) payloads
Procopiou, George
Jackson, Paul J.
di Mascio, Daniella M.
Auer, Jennifer L.
Andriollo, Paolo
Pysz, Ilona
Rahman, Khondaker M.
Fox, Keith R.
Thurston, David E.
CANCER RESEARCH, 2022, 82 (12)
[32] Analogues of DNA minor groove cross-linking agents incorporating aminoCBI, an amino derivative of the duocarmycins: Synthesis, cytotoxicity, and potential as payloads for antibody-drug conjugates
Giddens, Anna C.
Lee, Ho H.
Lu, Guo-Liang
Miller, Christian K.
Guo, Jun
Phillips, Gail D. Lewis
Pillow, Thomas H.
Tercel, Moana
BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (22) : 6075 - 6081
[33] Synthesis of new benzimidazole linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates with efficient DNA-binding affinity and potent cytotoxicity
Kamal, Ahmed
Kumar, P. Praveen
Sreekanth, K.
Seshadri, B. N.
Ramulu, P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (08) : 2594 - 2598
[34] RATIONALE FOR THE USE OF ALIPHATIC N-OXIDES OF CYTOTOXIC ANTHRAQUINONES AS PRODRUG DNA-BINDING AGENTS - A NEW CLASS OF BIOREDUCTIVE AGENT
PATTERSON, LH
CANCER AND METASTASIS REVIEWS, 1993, 12 (02) : 119 - 134
[35] Synthesis, DNA binding and cytotoxicity of 1-[[omega-(9-acridinyl)amino]alkyl]carbonyl-3-(chloromethyl)-6-hydroxyindolines, a new class of DNA-targeted alkylating agents
Fan, JY
Tercel, M
Denny, WA
ANTI-CANCER DRUG DESIGN, 1997, 12 (04): : 277 - 293

← 1 2 3 4 →